About Dr. Deepak Koppaka
Dr. Deepak Koppaka is a Consultant Medical Oncologist based in Hyderabad with 13+ years of experience across radiation oncology and medical oncology, specialising in chemotherapy, targeted therapy, immunotherapy and stem-cell transplantation for solid tumours and haematological malignancies. Trained at premier Indian institutions including PGIMER Chandigarh and Kidwai Memorial Institute of Oncology Bangalore, he is currently with CARE Hospitals, Hyderabad. He is widely regarded as one of the leading Medical Oncologist specialists in Hyderabad, India for international cancer patients seeking advanced systemic and personalised cancer therapy.
- 13+ years of clinical experience in oncology, with combined training in radiation and medical oncology
- Consultant Medical Oncologist — CARE Hospitals, HITEC City, Hyderabad
- Trained at PGIMER Chandigarh (MD Radiation Oncology, 2014) and Kidwai Memorial Institute of Oncology Bangalore (DM Medical Oncology, 2018)
- 98% patient rating and 99% recommendation rate across major Indian healthcare platforms
- Trained in autologous stem-cell transplant for lymphoma and multiple myeloma
- Member of ESMO, ASCO, AROI, ISMPO and Indian Society of Oncology
Qualifications & Credentials
Medical Degrees
- MBBS — G.S.L. Medical College, Rajahmundry, India, March 2011
- MD — Radiation Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, December 2014
- DM — Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India, July 2018
Fellowships & Special Training
- Senior Residency & Fellowship Training in Medical Oncology — Kidwai Memorial Institute of Oncology, Bangalore
- Training in autologous stem-cell transplantation for Hodgkin’s, Non-Hodgkin’s lymphoma and multiple myeloma
- Training at American Oncology Institute, Hyderabad — structural and interventional oncology
Certifications & Accreditations
- Andhra Pradesh / Telangana Medical Council — Registered Specialist
- Member, Association of Radiation Oncologists of India (AROI)
- Member, Indian Society of Medical and Paediatric Oncology (ISMPO)
- Member, Indian Society of Oncology
- Member, European Society for Medical Oncology (ESMO)
- Member, American Society of Clinical Oncology (ASCO)
Areas of Expertise
Major Conditions Treated
- Lung Cancer (Non-Small Cell & Small Cell)
- Breast Cancer (including Triple-Negative & HER2-Positive)
- Colorectal Cancer & Other GI Cancers
- Head and Neck Cancers
- Hodgkin and Non-Hodgkin Lymphomas
- Multiple Myeloma & Plasma Cell Disorders
- Acute Myeloid Leukaemia (AML) & Acute Lymphoblastic Leukaemia (ALL)
- Chronic Myeloid Leukaemia (CML) & Chronic Lymphocytic Leukaemia (CLL)
- Genitourinary Cancers (Prostate, Bladder, Kidney)
- Gynaecological Cancers (Cervical, Ovarian, Endometrial)
- Cancers in HIV/AIDS Patients
- Sarcomas & Rare Tumours
Sub-specialties
- Systemic Cancer Therapy: Chemotherapy, hormonal therapy, biological therapy, targeted therapy and immunotherapy for solid tumours and haematological malignancies — making him a leading Medical Oncologist specialist Hyderabad, India for personalised cancer therapy.
- Haemato-Oncology & Stem-Cell Transplantation: Induction and consolidation chemotherapy for AML/ALL and autologous stem-cell transplant for lymphoma and multiple myeloma — supporting demand for the best Medical Oncologist doctor in India for blood cancers.
- Onco-Procedures: Central line and PICC insertion, bone marrow aspiration and biopsy, image-guided tru-cut biopsies, FNAC, lumbar puncture and intrathecal drug administration.
Advanced Procedures & Treatments
- Chemotherapy (IV & Oral Regimens)
- Targeted Therapy (EGFR, ALK, HER2, BRAF, BTK inhibitors)
- Immunotherapy / Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)
- Hormonal Therapy (Breast, Prostate Cancer)
- Autologous Stem-Cell Transplant for Lymphoma & Multiple Myeloma
- Induction & Consolidation Chemotherapy for ALL / AML
- Central Line / PICC Insertion
- Bone Marrow Aspiration & Biopsy
- Image-Guided Tru-Cut Biopsies, FNAC, Pleural & Peritoneal Paracentesis
- Lumbar Puncture & Intrathecal Drug Administration
List of Disease and Treatment for which Dr. Deepak Koppaka can be consulted
Professional Experience
Current Affiliation
- Consultant Medical Oncologist — CARE Super Specialty Hospital, HITEC City, Hyderabad, Telangana, India (Present)
Past Affiliations
- American Oncology Institute / Citizens Specialty Hospital, Hyderabad — Consultant Medical Oncologist (Past)
- Sravani Hospitals, Madhapur, Hyderabad — Consultant Medical Oncologist (Past)
- K K Reddy Hospital, KPHB Colony, Hyderabad — Consultant Medical Oncologist (Past)
- Kidwai Memorial Institute of Oncology, Bangalore — DM Medical Oncology Trainee & Senior Resident, 2015–2018
- PGIMER, Chandigarh — MD Radiation Oncology Trainee, 2011–2014
Academic & Research Roles
- Author of multiple peer-reviewed publications in lung cancer, breast cancer, lymphoma and rare malignancies
- Author of book chapters on Non-Small Cell Lung Carcinoma and Gemcitabine-Induced Supraventricular Tachycardia
- Active speaker at oncology CMEs, conferences and tumour boards
Key Achievements
- Dual training in radiation oncology and medical oncology — rare in Indian oncology practice
- 13+ years of cumulative oncology experience across leading Indian cancer centres
- 98% patient rating and 99% recommendation rate
- Strong track record in HIV-associated malignancies and complex haematological cancers
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- Association of Radiation Oncologists of India (AROI)
- Indian Society of Medical and Paediatric Oncology (ISMPO)
- Indian Society of Oncology
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
Research & Publications
Published Papers (Selected)
- Koppaka D, Kapoor R, Bahl A, Bansal A, Mittal BR, et al. Impact of Integrating PET-CT in Radiotherapy Planning of Non-Small Cell Carcinoma Lung: Dosimetric and Radiobiological Comparison. Journal of Integrative Oncology. 2015;4:139.
- Abraham L, Rudresha A, Saldanha S, Koppaka D, et al. Gemcitabine-Induced Supraventricular Tachycardia: A Rare Manifestation. Clinical Cancer Investigation Journal. 2016;5:200–202.
- Lakshmaiah KC, Asati V, Babu KG, ..., Koppaka D, et al. Role of Pre-phase Treatment Prior to Definitive Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma. European Journal of Haematology. 2018.
- Rudresha AH, Anand A, Lakshmaiah KC, ..., Koppaka D. Clinicopathological Profile and Treatment Outcome of Squamous Cell Carcinoma Breast at a Tertiary Cancer Center in South India. Memo – Magazine of European Medical Oncology. 2017.
- Lakshmaiah KC, ..., Koppaka D. Role of Taxanes in Triple-Negative Breast Cancer: A Study from a Tertiary Cancer Center in South India. World Journal of Oncology. 2017;8:110–116.
- Kadabur L, Koppaka D, ..., Rajeev LK. Dual Mutations and Complex Mutations in Metastatic Non-Small Cell Lung Cancer: A Single-Institution Experience from South India. Indian Journal of Cancer. 2017;54:228–230.
Ongoing Research & Clinical Interests
- Targeted therapy and immunotherapy in lung cancer
- Triple-negative breast cancer outcomes
- Diffuse Large B-Cell Lymphoma management
- Cancer in patients with HIV/AIDS
- Stem-cell transplantation in haematological malignancies
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹600 – ₹1,500 | $7 – $20 |
| Chemotherapy (per cycle, regimen-dependent) | ₹20,000 – ₹1,50,000 | $240 – $1,800 |
| Targeted Therapy (per month, drug-dependent) | ₹50,000 – ₹3,00,000 | $600 – $3,600 |
| Immunotherapy (per cycle) | ₹80,000 – ₹2,50,000 | $960 – $3,000 |
| Autologous Stem-Cell Transplantation | ₹10,00,000 – ₹16,00,000 | $12,000 – $19,200 |
| Bone Marrow Aspiration & Biopsy | ₹6,000 – ₹15,000 | $72 – $180 |
| Tumour Marker / Molecular Profiling Panel | ₹5,000 – ₹50,000 | $60 – $600 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Deepak Koppaka use in Medical Oncologist treatment?
Dr. Deepak Koppaka employs the latest evidence-based tools and minimally invasive techniques relevant to Medical Oncologist. Virtual consultations and remote second opinions are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.
2. What conditions does Dr. Deepak Koppaka specialize in treating?
Dr. Deepak Koppaka is a specialist in Medical Oncologist, treating a broad spectrum of conditions in this field — including both common presentations and complex, rare cases. International patients seek treatment for conditions requiring expert Medical Oncologist care in Hyderabad, India.
3. How do I book an appointment with Dr. Deepak Koppaka?
Appointments with Dr. Deepak Koppaka can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Deepak Koppaka?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Deepak Koppaka, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Deepak Koppaka offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Medical Oncologist specialist in Hyderabad, India.


















